Patent №
US 9,352,020
Granted
2016-05-31
Filed 2013
Owner
MEAD JOHNSON NUTRITION COMPANY
+1 more
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13838539
The present disclosure provides a method for suppressing a proinflammatory response by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition may reduce the levels of proinflammatory cytokines and may be a treatment for inflammatory disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
AI classification
Ownership
MEAD JOHNSON NUTRITION COMPANY
assignment · 304590674
MEAD JOHNSON NUTRITION (ASIA PACIFIC) PTE. LTD.
correct · 304870471
Assignors
HONDMANN, DIRK, VAN TOL, ERIC A.F., GROSS, GABRIELE, SCHOEMAKER, MARIEKE H., LAMBERS, TEARTSE TIM
On an employer assignment, the assignors are typically the inventors.